Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha

Dushyant Verma; Hagop Kantarjian; Nitin Jain; Jorge Cortes

doi:10.1080/10428190802043903

Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha

Dushyant Verma
, Hagop Kantarjian
, Nitin Jain
, Jorge Cortes

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1399-1402
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	49
Issue number	7
DOIs	https://doi.org/10.1080/10428190802043903
State	Published - Jul 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428190802043903

Cite this

@article{cf1532b56b80469baac2b1428af29cdb,

title = "Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha",

author = "Dushyant Verma and Hagop Kantarjian and Nitin Jain and Jorge Cortes",

year = "2008",

month = jul,

doi = "10.1080/10428190802043903",

language = "English (US)",

volume = "49",

pages = "1399--1402",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

TY - JOUR

T1 - Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha

AU - Verma, Dushyant

AU - Kantarjian, Hagop

AU - Jain, Nitin

AU - Cortes, Jorge

PY - 2008/7

Y1 - 2008/7

UR - https://www.scopus.com/pages/publications/47649123285

UR - https://www.scopus.com/pages/publications/47649123285#tab=citedBy

U2 - 10.1080/10428190802043903

DO - 10.1080/10428190802043903

M3 - Article

C2 - 18452066

AN - SCOPUS:47649123285

SN - 1042-8194

VL - 49

SP - 1399

EP - 1402

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 7

ER -

Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this